Fig. (7) Activities of 11β-HSD type 1 in all tissues from both the control and GE-treated groups (* indicates P<0.05). [AM, abdominal muscle; QF, quadriceps femoris; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue].